Symptomatic intracranial stenosis: Best medical treatment vs. intracranial stenting

Current Opinion in Neurology

Volumn 22, Issue 1, 2009, Pages 69-74

  Lutsep, Helmi L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Angioplasty; Intracranial stenosis; Stent; Stroke; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; WARFARIN;

ANTICOAGULANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HIGH RISK POPULATION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; INTRACRANIAL STENOSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; OCCLUSIVE CEREBROVASCULAR DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; STENT; STENT THROMBOSIS; STROKE; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; ATHEROSCLEROSIS; CEREBROVASCULAR CIRCULATION; CLINICAL TRIALS AS TOPIC; CONSTRICTION, PATHOLOGIC; GRAFT OCCLUSION, VASCULAR; HUMANS; RISK FACTORS; STENTS; STROKE; VASCULAR DISEASES;

EID: 60449084475     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32831504e4     Document Type: Review

References (19)

1. Sacco RL, Kargman DE, Qiong G, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke 1995; 26:14-20.
2. Lutsep HL, Clark WM. Association of intracranial stenosis with cortical symptoms or signs. Neurology 2000; 55:716-718.
3. Feldmann E, Daneault N, Kwan E, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40:1541-1545.
4. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352:1305-1316.
5. Kasner SE, Chimowitz MI, Lynn MJ, et al., for the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113:555-563.
6. Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA Study. Neurology 2006; 66:1187-1191.
7. The SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA). Stroke 2004; 35:1388-1392.
8. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan Study. Stroke 2007; 38:1531-1537. The Wingspan Study reports prospective, multicenter outcome data for patients with symptomatic intracranial stenosis treated with the Wingspan Stent System.
9. Kurre W, Berkefeld J, Sitzer M, et al. Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology 2008; 50:701-708.
10. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIHS registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008; 70:1518-1524. The article provides prospective, postmarketing outcome and restenosis data for patients with symptomatic intracranial stenosis treated with the Wingspan Stent System.
11. Fiorella D, Levy E, Turk AS, et al, US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007; 38:881-887. This second prospective, postmarketing registry of patients with symptomatic intracranial stenosis treated with the Wingspan Stent System discusses periprocedural outcomes.
12. Levy El, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007; 61:644-651.
13. Turk AS, Levy El, Albuquerque FC, et al. Influence of patient age and stenosis location on Wingspan in-stent restenosis. Am J Neuroradiol 2008; 29:23-27.
14. Marks MP, Marcellus ML, Do HM, et al. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 2005; 26:525-530.
15. Derdeyn CP, Chimowitz MI. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am 2007; 17:355-363.
16. Maziighi M, Yadav JS, Abou-Chebl. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008; 39:1766-1769.
17. Anonymous. Stenting vs. Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS) trial [NCT00576693]. www.clinicaltrials.gov. [Accessed 27 June 2008].
18. Anonymous. Trial of Cilostazol in Symptomatic intracranial Arterial Stenosis II (TOSS-2) [NCT00130039]. www.clinicaltrials.gov. [Accessed 27 June 2008].
19. Anonymous. Cilostazol-aspirin therapy against recurrent stroke with intracranial artery stenosis [NCT00333164]. www.clinicaltrials.gov. [Accessed 27 June 2008].